NURS 330: Understanding UTIs

Lower Urinary Tract Infections (UTIs)

Overview

  • Definition: Lower urinary tract infections (UTIs) involve infections primarily in the bladder, leading to cystitis, which is the inflammation of the bladder.

  • Complications: UTIs may ascend to the kidneys, resulting in pyelonephritis, characterized by inflammation and infection of the kidneys.

Epidemiology

  • Prevalence: UTIs are significantly more prevalent in women due to anatomical factors—women possess a much shorter urethra, facilitating easier bacterial access to the bladder.

  • Primary Bacterial Source: The predominant source of bacteria for UTIs is fecal matter, with normal intestinal bacteria such as Escherichia coli (E. coli) being common culprits.

  • Transmission:

    • Anatomical access: Bacteria can swiftly reach the urethral opening from the anus due to short distance.

    • Sexual Activity: Involves the transfer of bacteria around the perineum, increasing infection risk.

    • Risk Factors: Include incontinence and poor personal hygiene.

    • Urinary Catheters: Catheters frequently serve as a significant source of infection, leading to catheter-associated urinary tract infections (CAUTIs), which are often more severe and difficult to treat.

Clinical Presentation

  • Typical Symptoms of Lower UTI:

    • Dysuria: Characterized by pain, stinging, or burning sensation during urination.

    • Suprapubic Pain: Discomfort or pain located in the lower abdominal region.

    • Increased Urinary Frequency: The need to urinate more frequently.

    • Urgency: A sudden, compelling urge to urinate.

    • Incontinence: Unintentional loss of urine.

    • Hematuria: Presence of blood in the urine, which can be microscopic or macroscopic.

    • Cloudy/Foul Smelling Urine: An indicator of UTI.

    • Confusion: Especially in older or frail patients, sometimes the only visible symptom.

Distinction from Pyelonephritis

  • Pyelonephritis:

    • A more serious condition compared to lower UTIs, with risks of significant complications including:

    • Sepsis

    • Kidney Scarring

    • Symptoms to Suspect Pyelonephritis: Fever, loin (flank) pain, back pain, nausea or vomiting, renal angle tenderness during examination.

Urine Dipstick Testing

  • **What to Test For: **

    • Nitrites: Indicate the breakdown of nitrates (normal waste) by gram-negative bacteria, specifically E. coli, suggesting bacterial presence in urine.

    • Leukocytes (White Blood Cells): Normal urine contains few leukocytes; significant increases indicate an infection or inflammation.

    • Leukocyte Esterase: A test measuring the product of leukocytes to estimate their concentration in urine.

    • Red Blood Cells (Hematuria): Presence in urine can indicate bladder infection, but can also be due to other conditions like bladder cancer or nephritis.

  • Types of Hematuria:

    • Microscopic Hematuria: Blood is detected via dipstick but is not visible to the naked eye.

    • Macroscopic Hematuria: Blood is visible in the urine.

  • Diagnostic Criteria:

    • Presence of either nitrites or leukocytes with red blood cells suggests a likely UTI. Treatment is typically required if both nitrites and leukocytes are present. If only nitrites are detected, treatment is often warranted. However, if only leukocytes show up without nitrites, treatment should be avoided unless clinical signs of infection are evident.

Midstream Urine Sample (MSU)

  • Purpose: A MSU sample is utilized for laboratory testing including microscopy, culture, and sensitivity (MCS), which is crucial for identifying the infective organism and selecting effective antibiotics.

  • Indications for MSU: Not all uncomplicated UTI cases require this, but it is essential in:

    • Pregnant patients

    • Patients with recurrent UTIs

    • Patients with atypical symptoms

    • Cases where symptoms fail to improve with antibiotics

Causes of Lower UTIs

  • Most Common Causative Agent:

    • E. coli: Gram-negative, anaerobic, rod-shaped bacteria present in the intestines. Their presence in feces can lead to UTIs.

  • Other Causes:

    • Klebsiella pneumoniae (gram-negative anaerobic rod)

    • Enterococcus species

    • Pseudomonas aeruginosa

    • Staphylococcus saprophyticus

    • Candida albicans (fungal cause)

Antibiotic Treatment

  • General Guidelines: Follow local antibiotic prescribing guidelines for UTIs.

  • Initial Antibiotics:

    • Trimethoprim: Commonly used but carries high resistance rates.

    • Nitrofurantoin: Caution advised in patients with renal impairment, specifically in those with an estimated glomerular filtration rate (eGFR) less than 45 mL/min.

  • Alternative Options:

    • Pivmecillinam

    • Amoxicillin

    • Cephalexin

Management of UTIs in Pregnancy

  • Risks Associated with UTIs in Pregnant Women:

    • Increased risk of pyelonephritis, premature rupture of membranes, and preterm labor.

  • Management Differences:

    • Seven-day course of antibiotics is necessary for urinary tract infections in pregnancy.

    • It is essential for all women to have a Midstream urine sample for MCS testing.

  • Safe Antibiotic Options in Pregnancy:

    • Nitrofurantoin: Avoid during the third trimester due to risk of neonatal hemolysis.

    • Amoxicillin: Should be administered only after sensitivity results are known.

    • Cephalexin

  • Contraindications:

    • Trimethoprim: Must be avoided during the first trimester as it acts as a folate antagonist essential for fetal development. Trimethoprim has potential teratogenic effects, particularly associated with neural tube defects. Not typically harmful in later pregnancy but should be used cautiously and primarily when necessary.